TRINIPATCH 15 mg/24 hours, medicated transdermal patch (67.2 mg / 21 cm²) 30 patches in individual sachets
Active ingredients: Nitroglycerin
Commercialized according to BDPMDispensing in France: Prescription only
Drug delivery system30 patches in individual sachetstransdermique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRINIPATCH 15 mg/24 heures, dispositif transdermique (67,2 mg / 21 cm²)
- Pharmaceutical form
- dispositif
- Route of administration
- transdermique
- Presentation description
- 30 sachet(s) P-A-M-éthylène (SURLYN) aluminium polyéthylène papier de 1 dispositif(s)
- Marketing authorisation holder
- T & A PHARMA (LUXEMBOURG)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Sept 1999
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63604206CIP73476708CIP133400934767081Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRINITRINEdispositif | 67,2 mg · un dispositif | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.